CStone Pharmaceuticals — Capital/Financing Update 2014

Dec 15, 2014

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities.

These materials contained in this announcement are not for distribution, publication or circulation, directly or indirectly, in or into the United States.

This announcement is solely for the purpose of reference and does not constitute an offer of securities for sale or an invitation to purchase securities in the United States or any other jurisdiction. The securities described herein have not been and will not be registered under the U.S. Securities Act of 1933 (the “ U.S. Securities Act ”) or under any securities laws of any state or other jurisdiction of the United States. Unless exempt from registration and in compliance with the securities laws of any state or other jurisdiction of the United States, the securities described herein may not be sold, offered for sale, resold, transferred or delivered, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act). There will be no public offer or sale of the securities described herein in the United States.

==> picture [63 x 60] intentionally omitted <==

兗州煤業股份有限公司

YANZHOU COAL MINING COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 1171)

FURTHER DEVELOPMENT IN RELATION TO THE RIGHTS OFFER

Reference is made to the circularof Yanzhou Coal Mining Company Limited (the " Company ") dated 27 November 2014 (the “ Circular ”) in relation to the Rights Offer by Yancoal Australia Limited (“ Yancoal Australia ”). Unless otherwise indicated, capitalized terms used in this announcement shall have the same meanings as those defined in the Circular.

On 15 December 2014, the Takeovers Panel of Australia made ordersin relation to the Rights Offer to the effect that:

• (a) Subject to paragraph (b) below, the Company and its associates may only exercise conversion rights in respect of the Convertible Hybrid Bonds subscribed by it with approval of shareholders of Yancoal Australia (excluding the Company and its

associates), such approval is to be determined by resolution approved by at least 50% of the votes cast byshareholders of Yancoal Australia entitled to vote on the resolution; and

• (b) The Company may from time to time, without the approval as required in paragraph (a) above, exercise its conversion rights in respect of the Convertible Hybrid Bonds subscribed by it to convert into such number of Conversion Shares as would allow the Company to maintain (but not increase) the level of its voting power in Yancoal Australia as at 15 December 2014 (i.e. approximately 78%).

By order of the Board Yanzhou Coal Mining Company Limited Li Xiyong

Chairman of the Board

Zoucheng, Shandong Province, the PRC 15 December2014

As at the date of this announcement, the directors of the Company are Mr. Li Xiyong, Mr. Zhang Xinwen, Mr. Yin Mingde, Mr. Wu Yuxiang, Mr. Zhang Baocai, Mr. Wu Xiangqian and Mr. Jiang Qingquan, and the independent non-executive directors of the Company are Mr. Wang Lijie, Mr. JiaShaohua, Mr. Wang Xiaojun and Mr. XueYouzhi.